In addition, the OS rate was significantly higher for NSCLC patients with low expression of p‐AKT, but there was no significant difference in multivariate analysis, which might partly make a compliment to the role of p‐AKT. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.